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Abstract
Chaperones are the primary regulators of the proteostasis network and are known to facilitate protein folding,
inhibit protein aggregation, and promote disaggregation and clearance of misfolded aggregates inside cells. We
have tested the effects of five chaperones on the toxicity of misfolded oligomers preformed from three
different proteins added extracellularly to cultured cells. All the chaperones were found to decrease oligomer
toxicity significantly, even at very low chaperone/protein molar ratios, provided that they were added
extracellularly rather than being overexpressed in the cytosol. Infrared spectroscopy and site-directed labeling
experiments using pyrene ruled out structural reorganizations within the discrete oligomers. Rather, confocal
microscopy, SDS-PAGE, and intrinsic fluorescence measurements indicated tight binding between oligomers
and chaperones. Moreover, atomic force microscopy imaging indicated that larger assemblies of oligomers are
formed in the presence of the chaperones. This suggests that the chaperones bind to the oligomers and
promote their assembly into larger species, with consequent shielding of the reactive surfaces and a decrease
in their diffusional mobility. Overall, the data indicate a generic ability of chaperones to neutralize
extracellular misfolded oligomers efficiently and reveal that further assembly of protein oligomers into larger
species can be an effective strategy to neutralize such extracellular species.
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Abstract 
Chaperones are the primary regulators of the proteostasis network and are known to facilitate 
protein folding, inhibit protein aggregation and promote disaggregation and clearance of misfolded 
aggregates inside cells. We have tested the effects of five chaperones on the toxicity of misfolded 
oligomers preformed from three different proteins added extracellularly to cultured cells. All the 
chaperones were found to decrease significantly oligomer toxicity even at very low 
chaperone/protein molar ratios, provided that they were added extracellularly rather than being 
overexpressed in the cytosol. Infrared spectroscopy and site-directed labelling experiments using 
pyrene ruled out structural reorganizations within the discrete oligomers. Rather, confocal 
microscopy, SDS-PAGE and intrinsic fluorescence measurements indicated tight binding between 
oligomers and chaperones. Moreover, AFM imaging indicated that larger assemblies of oligomers 
are formed in the presence of the chaperones. This suggests that the chaperones bind to the 
oligomers and promote their assembly into larger species, with consequent shielding of the reactive 
surfaces and a decrease in their diffusional mobility. Overall, the data indicate a generic ability of 
chaperones to neutralize efficiently extracellular misfolded oligomers and reveal that further 
assembly of protein oligomers into larger species can be an effective strategy to neutralize such 
extracellular species. 
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Introduction 
\body The ability of living systems to maintain their peptides and proteins in soluble and functional 
states is the result of evolutionary selection of the physicochemical and conformational 
characteristics of these macromolecules (1) and owing to an array of biological mechanisms that 
together act to ensure proteostasis (2). Failures of the protective and regulatory mechanisms can 
result in a wide variety of pathological conditions, including those associated with the accumulation 
of protein aggregates, both in the cytosol and in the extracellular space (3,4). Molecular chaperones 
are proteins that play a central role in the avoidance of protein misfolding and aggregation (5-8). 
Most known chaperones are intracellular (7,8), but some of them are secreted and are collectively 
referred to as extracellular chaperones (9). Chaperones are known to have a range of different 
functions, such as assisting in protein folding (7), inhibiting protein aggregation (10), causing the 
disaggregation of aberrant protein oligomers (6), and facilitating the degradation of misfolded 
proteins (11).  
In this study we have examined the effects of two intracellular and three extracellular 
chaperones on the toxicity of extracellularly added oligomers formed by three different 
peptides/proteins, namely the 42-residue amyloid β peptide (Aβ42), the islet amyloid polypeptide 
(IAPP) and the N-terminal domain of the HypF protein from E. coli (HypF-N). We focused our 
attention on small oligomers as such species are generally highly toxic to cultured cells and are 
thought to be the major deleterious species in a range of protein aggregation diseases (4). We show 
that the chaperones markedly decrease the toxicity of preformed oligomers, with significant effects 
being observed even at molar ratios of protein:chaperone as high as 500:1. We show in addition that 
chaperones bind to the oligomers and promote their clustering into larger aggregates, in the absence 
of any disaggregation or major structural reorganisation. Overall, these results provide suggestions 
on novel mechanisms by which molecular chaperones are cytoprotective extracellularly and also 
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reveal new determinants of protein oligomer toxicity and strategies to convert protein aggregates 
that are toxic to cultured cells into innocuous species. 
 
RESULTS 
 
Chaperones reduce oligomer toxicity. 
We generated toxic oligomers from Aβ42, IAPP and HypF-N, as described previously (12-14). After 
1 h incubation in the cell culture medium, they were added to human SH-SY5Y neuroblastoma 
cultured cells, at a corresponding monomer concentration of 12 µM. Under these conditions, all 
oligomers were found to decrease the MTT reduction of the cells by 30-40%, demonstrating their 
toxic nature (Fig. 1A). The oligomers were then subjected to the same procedure but incubated for 1 
h in the cell culture medium containing either αB-crystallin (αBcr), Hsp70, clusterin (Clu), 
haptoglobin (Hp) or α2-macroglobulin (α2M) before their addition to SH-SY5Y cells. For these five 
chaperones and for all our experiments, the protein:chaperone molar ratios were 5:1, 5:1, 10:1, 15.1 
and 100:1, respectively, unless otherwise stated. In each case the cells were found to reduce MTT to 
levels similar to untreated cells and to cells treated with the native proteins (Fig 1A). Hsp70 was 
found to be equally effective with or without ATP (SI Appendix. Fig. S1).  
When the oligomers were incubated in the cell culture medium with proteins that do not act as 
chaperones, either hen lysozyme (HEWL) or bovine serum albumin (BSA), they maintained their 
toxicity (Fig. 1A). Moreover, chaperones were not found to be protective against other forms of 
stress, such as H2O2-mediated oxidation (SI Appendix. Fig. S2). These results therefore indicate 
that all five chaperones markedly decrease the toxicity of oligomers formed by three different 
proteins, with these effects being specific to the chaperones (relative to other proteins) and to 
protein oligomer toxicity (relative to other forms of stress). 
The experiments with HypF-N oligomers and chaperones were repeated by varying the 
concentrations of each of the five chaperones (from 2.4 µM to 6 nm), while maintaining constant 
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that of HypF-N (12 µM). All chaperones had significant effects even at HypF-N:chaperone molar 
ratios of 500:1, becoming ineffective only at molar ratios of 2000:1 (Fig. 1B). Thus, chaperones 
appear to markedly decrease oligomer toxicity at greatly sub-stoichiometric concentrations. The 
experiments were repeated with HypF-N, Aβ42 and IAPP oligomers (12 µM) using varying 
concentrations of antibodies sequence-specific to the proteins (from 2.4 µM to 6 nm). Compared to 
the chaperones, higher concentrations of antibodies were required to reduce the toxicity of the 
respective oligomers (SI Appendix. Fig. S3). 
 
Chaperones prevent the interaction of oligomers with cellular membranes. 
For the following experiments we chose to focus on the oligomers from a single protein, HypF-N. 
Indeed, under different experimental conditions, HypF-N can aggregate into toxic (type A, the same 
used in the present work) or nontoxic (type B) oligomers; the two species are morphologically 
similar as determined by atomic force microscopy (AFM) and bind Thioflavin T (ThT) to similar 
levels, making it possible to carry out valuable control experiments (14). In addition, differences in 
the structure of toxic and nontoxic oligomers have been detected using the fluorescent probe N-(1-
pyrene)maleimide (PM) (14), providing a valuable method to probe structural changes experienced 
by the oligomers following their exposure to chaperones (see below). 
HypF-N oligomers have been shown to be toxic via aberrant interactions with the cell 
membrane, causing a rapid influx of Ca2+ ions from the cell culture medium to the cytosol (15). 
This triggers a slower and complex cellular cascade manifested by increases in intracellular ROS 
and in caspase-3 activity, and as a release of intracellular calcein from cells, eventually leading to 
apoptosis (15). Pre-incubation of HypF-N oligomers (12 µM monomer) with each of the five 
chaperones in the cell culture medium for 1 h, prior to addition to the cells, was found to inhibit the 
increase of intracellular Ca2+ levels caused by the oligomers (Fig. 2), with the degree of inhibition 
increasing with pre-incubation time (SI Appendix. Fig. S4). All other events were also reduced 
markedly, with the extent of reduction again being dependent on the time of pre-incubation (SI 
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Appendix. Fig. S5-7). We conclude, therefore, that all five chaperones examined here can inhibit 
the initial biochemical events induced by toxic HypF-N oligomers, namely the influx of Ca2+, thus 
eliminating the occurrence of later downstream effects. In addition, the observed dependence of the 
degree of protection on the pre-incubation time indicates that the chaperones generically reduce 
toxicity by interacting with the oligomers, rather than through a separate protective pathway 
mediated by interaction of the chaperones with the cells. 
Extracellular chaperones can interact with misfolded proteins and are thought to facilitate their 
clearance via endocytosis mediated by cell surface receptors, such as the lipoprotein receptor-
related proteins 1 and 2 (LRP-1 and LRP-2) or scavenger receptors (9). This possibility was 
however excluded in our system, as shown by confocal microscopy and anti-HypF-N antibodies (SI 
Appendix. Fig. S8-9). In fact, HypF-N oligomers, unlike the native protein and nontoxic oligomers, 
were found to be internalised following pre-incubation for 1 h in the absence of chaperones. 
Analysis of the confocal images at median planes parallel to the coverslip revealed that HypF-N 
appeared inside the cells only upon treatment with the toxic oligomers. (SI Appendix. Fig. S8B). 
Pre-incubation of the oligomers with each chaperone led to little or no HypF-N entry (SI Appendix. 
Fig. S8-9). The oligomers were predominantly detected outside or attached to the cells, but not 
within them, as confirmed by analysing the confocal images at median planes. These observations 
therefore show that the chaperones inhibit oligomer internalisation, at least under the conditions 
used here, rather than stimulating their intracellular degradation following endocytosis. 
We next took advantage of human embryonic kidney 293 (HEK293) cell lines overexpressing 
either human Hsp70 (HSPA1A) or Hsp22 (HSPB8) in the cytosol (16,17); the latter is a small heat 
shock protein containing an α-crystallin domain. Both cell lines were found to be resistant to 
intracellular protein aggregation-associated cell death (SI Appendix. Fig. S10) (16,17). As observed 
with the SH-SY5Y cells, treatment of wild-type HEK293 cells with HypF-N oligomers caused a 
decreased MTT reduction by 41±8%, whereas pre-incubation of the oligomers with either Hsp70 or 
αBcr prevented such an effect (SI Appendix. Fig. S10). Importantly, the HypF-N oligomers were 
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also toxic to HEK293 cells overexpressing Hsp70 or Hsp22, but pre-incubation of the oligomers 
with Hsp70 or αBcr prevented their toxicity in the corresponding cell lines (SI Appendix. Fig. S10). 
Overall, therefore, the deleterious effects of HypF-N oligomers can be abolished by chaperones 
provided that the chaperone-oligomer interactions occur before the oligomers are able to interact 
with the cell membranes and initiate the Ca2+ influx. In agreement with this conclusion, chaperones 
overexpressed intracellularly are not protective against extracellular oligomers. 
 
Chaperones bind to and assemble the oligomers into larger species. 
Three possible non-exclusive molecular mechanisms can be hypothesised to explain how 
chaperones reduce oligomer toxicity: (i) the chaperones disassemble the oligomers; (ii) they bind to 
oligomers and promote their assembly into larger and innocuous aggregates, (iii) they catalyse a 
structural reorganisation into nontoxic forms. The ability of HypF-N oligomers to bind ThT was 
maintained following pre-incubation with each of the chaperones, whereas neither native HypF-N 
nor free chaperones had such an ability (SI Appendix. Fig. S11). A process of chaperone-mediated 
oligomer disassembly can thus be excluded. 
To investigate whether chaperones bind to the oligomers and promote their further assembly, 
we first used AFM. Discrete oligomers with a height of 2-6 nm were observed by AFM in the 
absence of chaperones (Fig. 3A), but significantly larger aggregates are evident with αBcr (Fig. 3B) 
or α2M (Fig. 3C), used here as representative chaperones. On higher magnification of these images, 
the aggregates appear as clusters of oligomers (Fig. 3D). In some cases more complex structures are 
observed, consisting of very large aggregates of irregular shape with typical heights of a few tens of 
nm, often surrounded by clusters of more distinct oligomers. Large assemblies are not observed in 
samples containing only chaperones (Fig. 3E,F).  
The AFM data show that chaperones promote the assembly of the oligomers into larger species, 
but do not provide information on whether or not the chaperones remain bound to them. The 
oligomers can also be observed with confocal microscopy as, unlike free chaperones, they readily 
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adhere to the glass coverslips (Fig. 3G). Images obtained using oligomers pre-incubated with αBcr 
or α2M show larger aggregates and co-localisation of the chaperones with the large oligomer 
clusters (Fig. 3H,I). Although this technique has a resolution that enables only visualisation of 
clusters of oligomers or areas enriched with oligomers (not individual oligomers), it shows that the 
chaperones are bound to the large clusters of oligomers. 
In another experiment, samples of HypF-N oligomers incubated with each chaperone were 
centrifuged to separate the soluble (supernatant, SN) and insoluble (pellet, P) fractions, which were 
then analysed by SDS-PAGE. In the control samples containing oligomers or αBcr alone, the HypF-
N monomer (MW ~10.5 kDa) and the αBcr monomer (MW ~20 kDa) bands were found only in the 
P and SN fractions, respectively (Fig. 4A). In the sample containing both species, the HypF-N band 
was found only in the P fraction, whereas αBcr was found to partition between the P and SN 
fractions (Fig. 4A). This finding indicates that a fraction of αBcr is bound to the oligomers. 
Moreover, the αBcr found in the P fraction remains tightly associated with the oligomers after 
resuspension of the pellet and further incubation (SI Appendix. Fig. S15). Similar results were 
obtained using α2M (Fig. 4B), Hsp70 (SI Appendix. Fig. S12A), Clu (SI Appendix. Fig. S13A) and 
Hp (SI Appendix. Fig. S14A). The results, therefore, confirm that binding occurs between the 
oligomers and all five chaperones studied here. Intrinsic fluorescence spectra of the SN fractions 
collected in each experiment were also acquired (Fig. 4C, 4D and SI Appendix. Fig. S12B, S13B, 
S14B). The SNs obtained from the samples where both oligomers and chaperones were present 
yielded fluorescence spectra that were less intense than the corresponding samples in which only 
the chaperone was present, confirming that a fraction of the chaperone population had been 
separated through centrifugation. 
Overall, the AFM data indicate that chaperones promote the assembly of the oligomers into 
larger species, whereas the other methods of analysis indicate that the chaperones are bound to the 
assembled oligomers. The finding that a small fraction of chaperones is bound to the oligomers, 
prompted by SDS-PAGE and intrinsic fluorescence measurements, suggests that chaperones act as 
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nucleation sites for the assembly of oligomers into larger species and explains why they are 
effective in reducing markedly oligomer toxicity even at highly sub-stoichiometric concentrations. 
 
The molecular structure of the oligomers is preserved after chaperone interaction.  
As a next step we set out to assess if chaperones promote a structural reorganisation of the 
oligomers, in addition to inducing their assembly. We took advantage of the ability to discriminate 
between the toxic HypF-N oligomers used in this work (type A) and nontoxic ones (type B) through 
the measurement of the fluorescence properties of oligomers labelled with PM at different positions 
in the sequence (14). This probe monitors the presence of a short distance (≤10Å) between labelled 
positions in the oligomers, which becomes evident as an excimer band at 440 nm (14). In particular, 
the fluorescence spectra of nontoxic oligomers formed by HypF-N labelled with PM at position 25, 
55 or 87 show an excimer band at 440 nm that is very weak in the corresponding spectra obtained 
with PM-labelled toxic oligomers (Fig. 5A) (14). The fluorescence spectra obtained for the toxic 
oligomers labelled at each position after incubation with or without αBcr or α2M are very similar 
and all show the absence of an excimer band (Fig. 5A), excluding a structural conversion. Similar 
data were obtained with Hsp70, Clu and Hp (SI Appendix. Fig. S12C, 13C, 14C).  
We extended our analysis to oligomers formed from 1:1 mixtures of HypF-N monomers 
labelled with PM at 5 different positions (residues 10, 25, 47, 55, 87), thereby obtaining excimer 
ratio values for a total of 15 differently labelled HypF-N oligomers. The patterns of 15 excimer 
ratio values obtained in the presence of αBcr or α2M, used as representative chaperones, are 
essentially identical to the pattern obtained in their absence (Fig. 5B), indicating that the spatial 
distribution of residues in the oligomers is preserved following interaction with the chaperones. 
Furthermore, examination with Fourier transform infra-red (FTIR) spectroscopy indicated 
that no changes in secondary structure appeared to have occurred following the incubation of the 
oligomers with either αBcr or α2M (Fig. 5C). 
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Discussion 
Our data show that chaperones inhibit the cellular toxicity of extracellular protein oligomers under 
the conditions studied here. This behaviour appears to result from the ability of the chaperones to 
bind to oligomers and promote their further assembly into larger species, in the absence of any 
significant reorganisation of their internal molecular structure. This mechanism is extremely 
effective as it allows the chaperones to reduce oligomer toxicity at highly sub-stoichiometric levels. 
Such an ability of molecular chaperones adds to their well established functions in 
facilitating protein folding, inhibiting protein aggregation and promoting the disaggregation and 
clearance of protein aggregates (6,7,10,11). In all our experiments the oligomers are formed before 
adding the chaperones, showing that the protective action of the latter also includes neutralisation of 
toxic oligomers after they have formed. This protective mechanism is not entirely novel, but 
evidence has been very sparse in the past, with reports often being contradictory and with undefined 
mechanisms (9,18-22). 
These data also suggest that the size of extracellular protein aggregates is an inverse 
correlate of their toxicity. The chaperone-induced oligomer clusters are characterised by a reduction 
in their exposed hydrophobic surface and diffusional mobility, both of which are expected to reduce 
their toxicity to cells. It is therefore clear that chaperones can be valuable tools for understanding 
the factors governing oligomer toxicity. 
Importantly, the results shown here suggest that the structure, function and mechanism of 
action of molecular chaperones may serve to guide the design of therapeutic interventions against 
diseases originating from extracellular protein aggregation. Indeed, the finding that natural 
molecular chaperones can inhibit the toxicity of aberrant protein aggregates after they are formed, 
with broad specificity and at very low concentrations, suggests that therapeutics based on the same 
type of intervention could be effective against such diseases. 
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Materials and methods 
 
Proteins 
HypF-N was purified as previously described (14). Aβ42 and IAPP were purchased from Sigma-
Aldrich (St. Louis, MO). Human Hsp70 and αBcr were purified as previously described (23,24). 
Human Clu, α2M and Hp were purified as previously reported (25-27). BSA and HEWL were 
obtained from Sigma-Aldrich. 
 
Formation of protein oligomers 
HypF-N was converted into toxic (type A) or nontoxic (type B) aggregates as previously reported 
(14). Oligomers were centrifuged at 16100g for 10 min, dried under N2 and resuspended in the cell 
culture medium without cells (for cell biology tests) or in 20 mM phosphate buffer, pH 7.0 (for 
biophysical/biochemical analysis). No significant dissolution of the oligomers or change in 
morphology/structure could be detected after this procedure, as previously reported (14). Toxicity 
was measured in all cases under physiological conditions (pH 7.4, 37 °C, no organic solvents). Aβ42 
and IAPP oligomers were prepared as previously described (12,13) and resuspended in the cell 
culture medium to 12 µM. Native proteins were diluted to 12 µM into the same medium. All 
oligomers were then incubated in the appropriate media for 1 h at 37 °C while shaking, without or 
with chaperones, and then added to cultured cells or subjected to biophysical/biochemical analysis. 
The HypF-N(Aβ42/IAPP):chaperone molar ratio was 5:1 (αBcr), 5:1 (Hsp70), 10:1 (Clu), 15:1 (Hp) 
and 100:1 (α2M), unless stated otherwise (all proteins are considered as monomers, except Clu and 
Hp as αβ dimers and α2M as a tetramer). 
 
MTT reduction assay 
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Oligomers of HypF-N, Aβ42 and IAPP (at a corresponding monomer concentration of 12 µM) were 
incubated for 1 h without or with αBcr, Hsp70, Clu, Hp, α2M, HEWL or BSA (HypF-N:chaperone 
molar ratios as described above, HypF-N:HEWL and HypF-N:BSA molar ratios were 5:1), and then 
added to SH-SY5Y cells. The MTT reduction assay was performed as previously described (14). 
Further details are give in Supplementary Methods. 
 
Measurement of intracellular Ca2+ 
HypF-N oligomers (at a corresponding monomer concentration of 12 µM) were incubated for 1 h in 
the cell culture medium without or with αBcr, Hsp70, Clu, Hp or α2M and then added to SH-SY5Y 
cells seeded on glass coverslips for 60 min at 37 °C. Cells were then loaded with 10 µM fluo3-AM 
(Molecular Probes, Eugene, OR), as previously described (14,15). Cells were also treated with 
nontoxic HypF-N oligomers or the native protein (12 µM monomer). Cell fluorescence was 
analysed by confocal scanning microscopy, as previously described (14,15). 
 
AFM 
Samples prepared as detailed above were diluted from 5 to 100 times, as required, and 10 μl 
aliquots were deposited on freshly cleaved mica and dried under mild vacuum. Tapping mode AFM 
images were acquired in air using a Multimode SPM, equipped with a “E” scanning head 
(maximum scan size 10μm) and driven by a Nanoscope IV controller, and a Dimension 3100 SPM, 
equipped with a ‘G’ scanning head (maximum scan size 100μm) and driven by a Nanoscope IIIa 
controller (Digital Instruments, Bruker AXS GmbH, Karlsruhe, Germany). Single beam uncoated 
silicon cantilevers (type OMCL-AC160TS, Olympus, Tokyo, Japan) were used. The drive 
frequency was 290-310 kHz, the scan rate was 0.4-0.8 Hz. Aggregate sizes were measured from the 
height in cross section of the topographic AFM images. The reported heights result from the 
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obtained values multiplied by a shrinking factor of 2.2, which was evaluated comparing the heights 
of native HypF-N under liquid and after drying. 
 
Confocal microscopy analysis for chaperone-oligomer binding 
HypF-N oligomers (at a corresponding monomer concentration of 48 µM) were incubated for 1 h 
without or with αBcr or α2M and then centrifuged to obtain pellets which were resuspended and 
incubated subsequently for 30 min at 37 °C in solutions containing: (i) 1:4000 rabbit polyclonal 
anti-HypF-N antibodies (Primm, Milan, Italy) and goat polyclonal anti-αBcr antibodies or goat 
polyclonal anti-α2M antibodies (Santa Cruz Biotech, Santa Cruz, CA); (ii) 1:1000 Alexa Fluor 488-
conjugated anti-rabbit secondary antibodies (Molecular Probes); (iii) 1:4000 Texas red-conjugated 
anti-goat secondary antibodies (Santa Cruz Biotech). After every incubation, samples were 
centrifuged for 10 min at 16100g, washed in PBS and centrifuged again. Finally, the P was 
resuspended in 20 µl PBS and spotted on glass coverslips. The cross-reactivity of oligomers was 
tested by subsequent incubations with primary and secondary anti-αBcr or anti-α2M antibodies. 
Confocal microscope images were acquired as previously described (14). 
 
SDS-PAGE 
HypF-N oligomers, αBcr and α2M were incubated for 1 h in 20 mM phosphate buffer at pH 7.0 in 
isolation and in combination (48 µM HypF-N). Samples were then centrifuged for 10 min at 
16100g. Aliquots of the P and SN fractions were subjected to SDS-PAGE using 15% 
polyacrylamide gels. 
 
Intrinsic fluorescence 
Intrinsic fluorescence spectra of the SN fractions collected for SDS-PAGE were acquired at 37 °C 
using a Perkin-Elmer LS 55 spectrofluorimeter (Wellesley, Massachusetts) and a 2X10mm quartz 
cell, an excitation wavelength of 280 nm. The spectrum of HypF-N oligomers was subtracted from 
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that of the chaperone in the presence of HypF-N oligomers and all the spectra were normalized to 
the maximum fluorescence intensity of the chaperone spectrum. 
 
Pyrene fluorescence 
HypF-N variants carrying a single cysteine residue were labelled with PM as previously described 
(14), converted into toxic and nontoxic oligomers in homogeneous or 1:1 mixtures and then diluted 
4-fold into 20 mM phosphate buffer at pH 7.0. Fluorescence emission spectra of these samples were 
acquired after 1 h without or with chaperones and analyzed as previously described (14). HypF-N 
concentration was 12 µM. 
 
FTIR spectroscopy 
HypF-N oligomers were incubated with or without αBcr or α2M (48 µM HypF-N) and then 
centrifuged and resuspended in D2O twice to achieve a final protein concentration of ~15 mg ml-1. 
The sample was deposited on a KBr window in a semipermanent liquid cell and the FTIR spectra 
were recorded at room temperature using an FT/IR 4200 spectrophotometer (Jasco, Tokyo, Japan). 
The system was constantly purged with N2. The resulting spectra were baseline corrected and 
smoothed. 
 
Statistical analysis 
All data were expressed as means ± standard deviation (SD). Comparisons were performed using 
ANOVA followed by Bonferroni’s post-comparison test. 
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Figure Legends 
 
Fig. 1. Reduction of protein oligomer toxicity by chaperones. (A) Preformed oligomers of HypF-
N, Aβ42 and IAPP were resuspended in the cell culture medium at a corresponding monomer 
concentration of 12 µM, incubated for 1 h without or with the indicated chaperones or control 
proteins, and then added to the cell culture medium of SH-SY5Y cells. The asterisks indicate 
p≤0.01 relative to the experiment without chaperones. (B) Similarly treated HypF-N oligomers (12 
µM monomer) were incubated for 1 h without (O) or with the indicated chaperones at the indicated 
HypF-N:chaperone molar ratios, and then added to SH-SY5Y cells. The scale on the x axis is 
logarithmic. 
 
Fig. 2. Reduction of HypF-N oligomer-induced intracellular free Ca2+ influx by chaperones. 
Confocal microscope images of SH-SY5Y cells showing intracellular free Ca2+ following exposure 
to HypF-N oligomers (at a corresponding monomer concentration of 12 µM) pre-incubated with or 
without the indicated chaperones. The green fluorescence arises from the intracellular Fluo3 probe 
bound to Ca2+. 
 
Fig. 3. Assembly of HypF-N oligomers induced by chaperones. (A-F) AFM images (left, height 
data; right, amplitude data) showing oligomers and chaperones pre-incubated in phosphate buffer 
alone or in combination, as indicated; scan size, 630 nm. (D) Enlargement of a 250x250 nm portion 
of (B). Z range: 10 nm (A), 13 nm (B,D), 25 nm (C), 6 nm (E), 10 nm (F). (G) Representative 
confocal microscope images showing HypF-N oligomers without chaperones and treated with anti-
α2M (red), anti-αBcr (red) or anti-HypF-N (green) antibodies, as indicated. The absence of red 
fluorescence indicates the absence of cross-reaction. (H,I) Images showing HypF-N oligomers 
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incubated with αBcr (H) or α2M (I) and treated with the same three antibodies, as indicated. The co-
localization of oligomers and chaperones is shown in the merged images (yellow). 
 
Fig. 4. Binding of chaperones to HypF-N oligomers. (A) SDS-PAGE analysis of the P and SN 
fractions of samples containing HypF-N oligomers (lanes 2,3), αBcr (lanes 4,5) and oligomers with 
αBcr (lanes 6,7). The bands at ~10 and 20 kDa indicate monomeric HypF-N and αBcr, respectively. 
The HypF-N concentration was 48 µM. (B) SDS-PAGE analysis for α2M; conditions and lanes as in 
(A). The α2M bands range from ~ 60 kDa to ~ 160 kDa. (C) Intrinsic fluorescence spectra of the SN 
fractions of samples containing HypF-N oligomers (dotted line), αBcr (solid line) and oligomers 
with αBcr (dashed line). The spectrum of HypF-N oligomers has been subtracted from that of 
chaperone plus oligomers to clear the contribution of the former. All spectra are the means of three 
experiments. (D) Intrinsic fluorescence analysis of α2M. Conditions and spectra as in (C). 
 
Fig. 5. Lack of structural reorganization of HypF-N oligomers following treatment with 
chaperones. (A) Fluorescence emission spectra of HypF-N oligomers labelled with PM at positions 
25 (top graphs), 55 (middle graphs) and 87 (bottom graphs). The HypF-N concentration was 12 
µM. The spectra refer to oligomers incubated in 20 mM phosphate buffer, pH 7.0 without (black) 
and with αBcr (red) or α2M (purple). For comparison, the corresponding spectra of nontoxic 
oligomers are reported in each graph (green). The spectra are normalized to the intensity of the peak 
centred at 375 nm. The vertical lines at 440 nm indicate the position of the excimer band. (B) Ratios 
between the PM fluorescence intensities measured at 440 nm (excimer peak) and 375 nm (PM 
monomer peak) for HypF-N oligomers prepared with 1:1 mixtures of HypF-N chains PM-labelled 
at positions 10, 25, 47, 55 and 87. Colours as in (A). The total HypF-N concentration was 12 μM. 
The SD are reported in brackets. (C) FTIR amide I spectra of HypF-N oligomers after incubation 
without (black) and with αBcr (red) or α2M (purple). 
 





